ANNEX 2.
| Table A.1 | Summary of key strategies and policies of national malaria control programmes |
| Table A.2 | Antimalarial drug policy, end 2004 |
| Table A.3 | Summary of finances available for malaria control (in US$ thousands) |
| Table A.4 | Summary of committed and disbursed malaria funds available from the Global Fund to Fight AIDS, Tuberculosis and Malaria (in US$) |
| Table A.5 | Summary of malaria-related service delivery |
| Table A.6 | Summary of antimalarial drug efficacy results expressed as treatment failure |
| Table A.7 | Percentage of households that have at least one mosquito net, by background characteristics |
| Table A.8 | Percentage of households that have at least one insecticide-treated net, by background characteristics |
| Table A.9 | Percentage of children under 5 years of age that slept under a mosquito net during the night preceding the survey, by background characteristics |
| Table A.10 | Percentage of children under 5 years of age that slept under an insecticide-treated net during the night preceding the survey, by background characteristics |
| Table A.11 | Percentage of pregnant women that slept under a mosquito net during the night preceding the survey, by background characteristics |
| Table A.12 | Percentage of pregnant women that slept under an insecticide-treated net during the night preceding the survey, by background characteristics |
| Table A.13 | Percentage of children under 5 years of age with reported fever in the two weeks prior to the survey, by background characteristics |
| Table A.14 | Percentage of febrile children under 5 years of age who received treatment with CQ, by background characteristics |
| Table A.15 | Percentage of febrile children under 5 years or age who received treatment with SP, by background characteristics |
| Table A.16 | Percentage of febrile children under 5 years of age who received treatment with any antimalarial, by background characteristics |
| Table A.17 | Pregnant women receiving SP at least once during pregnancy (community level, prevention or treatment), by background characteristics |
| Table A.18 | Pregnant women receiving SP at least twice during pregnancy (community level, prevention or treatment), by background characteristics |
| Table A.19 | Pregnant women receiving SP at least once during an antenatal visit, by background characteristics |
| Table A.20 | Pregnant women receiving SP at least twice during an antenatal visit, by background characteristics |
| Table A.21 | Reported malaria for the most recent year information received |
| Table A.22 | Standardized reported malaria cases and rates per 1000 since 1990 |